Theophylline and dexamethasone in combination reduce inflammation and prevent the decrease in HDAC2 expression seen in monocytes exposed to cigarette smoke extract

Sun,Xue‑Jiao; Li,Zhan‑Hua; Zhang,Yang; Zhong,Xiao‑Ning; He,Zhi‑Yi; Zhou,Ji‑Hong; Chen,Si‑Ning; Feng,Yuan

doi:10.3892/etm.2020.8584

Theophylline and dexamethasone in combination reduce inflammation and prevent the decrease in HDAC2 expression seen in monocytes exposed to cigarette smoke extract

Authors:
- Xue‑Jiao Sun
- Zhan‑Hua Li
- Yang Zhang
- Xiao‑Ning Zhong
- Zhi‑Yi He
- Ji‑Hong Zhou
- Si‑Ning Chen
- Yuan Feng
View Affiliations

Affiliations: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Respiratory Medicine, Ruikang Hospital Affiliated to Guangxi Traditional Chinese Medicine University, Nanning, Guangxi 530021, P.R. China
Published online on: March 6, 2020 https://doi.org/10.3892/etm.2020.8584
Pages: 3425-3431

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung and systemic inflammation are associated with impaired lung function and increased mortality in patients with chronic obstructive pulmonary disease (COPD). Theophylline and glucocorticoids have been shown to have an anti‑inflammatory effect in some respiratory diseases. However, corticosteroid insensitivity is a major barrier to the anti‑inflammatory management of COPD. This study aimed to explore whether a combined treatment of theophylline and dexamethasone (Dex) could decrease cigarette smoke extract (CSE)‑induced inflammation via prevention of a reduction in histone deacetylase 2 (HDAC2) expression and through inhibition of the PI3K/Akt pathway, which may be related to corticosteroid sensitivity. The half‑maximal inhibitory concentration (IC50) of Dex (IC50‑Dex) was used to as a marker of corticosteroid sensitivity. IC50‑Dex was determined through observation of Dex inhibition of tumor necrosis factor‑α (TNF‑α)‑induced interleukin (IL)‑8 release. Using reverse transcription quantitative PCR and western blotting, U937 cells treated with CSE were assessed for HDAC2 expression levels and phosphorylation levels of Akt. Theophylline and Dex pre‑treatment was shown to significantly reduce the CSE‑induced release of IL‑8 and TNF‑α. The combination of theophylline and Dex pretreatment also reversed corticosteroid insensitivity in CSE‑induced U937 cells and inhibited the PI3K/AKT pathway to a greater extent than theophylline treatment alone. CSE‑treated U937 cells showed a reduction in HDAC2 mRNA and protein expression compared with the control group. However, this effect was reduced after pre‑incubation with the combined therapy or theophylline alone. In conclusion, pretreatment with theophylline and Dex decreased CSE‑induced inflammation via inhibition of the PI3K/Akt pathway and increase in HDAC2 protein expression.

View Figures

View References

1	Osthoff M, Jenkins C and Leuppi J: Chronic obstructive pulmonary disease-a treatable disease. Swiss Med Wkly. 143(w13777)2013.PubMed/NCBI View Article : Google Scholar
2	Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barns PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.PubMed/NCBI View Article : Google Scholar
3	Kirkham P and Rahman I: Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy. Pharmacol Ther. 111:476–494. 2006.PubMed/NCBI View Article : Google Scholar
4	Barnes P: Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 161:341–342; discussion 344. 2000.PubMed/NCBI View Article : Google Scholar
5	Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL and Barnes PJ: Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 160:1635–1639. 1999.PubMed/NCBI View Article : Google Scholar
6	Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK and Barnes NC: The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 165:1592–1596. 2002.PubMed/NCBI View Article : Google Scholar
7	Ford PA, Durham AL, Russell RE, Gordon F, Adcock IM and Barnes PJ: Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest. 137:1338–1644. 2010.PubMed/NCBI View Article : Google Scholar
8	Kobayashi Y, Wada H, Rossios C, Takagi D, Charron C, Barnes PJ and Ito K: A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition. Br J Pharmacol. 169:1024–1034. 2013.PubMed/NCBI View Article : Google Scholar
9	To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM and Barnes PJ: Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182:897–904. 2010.PubMed/NCBI View Article : Google Scholar
10	Barnes PJ, Adcock IM and Ito K: Histone acetylation and deacetylation: Importance in inflammatory lung diseases. Eur Respir J. 25:552–563. 2005.PubMed/NCBI View Article : Google Scholar
11	Rahman I and Adcock IM: Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 28:219–242. 2006.PubMed/NCBI View Article : Google Scholar
12	Sun X, Li Q, Gong Y, Ren L, Wan H and Deng W: Low-dose theophylline restores corticosteroid responsiveness in rats with smoke-induced airway inflammation. Can J Physiol Pharmacol. 90:895–902. 2012.PubMed/NCBI View Article : Google Scholar
13	De Ruijter AJ, van Gennip AH, Caron HN, Kemp S and van Kuilenburg AB: Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J. 370:737–749. 2003.PubMed/NCBI View Article : Google Scholar
14	Barnes PJ and Adcock IM: Glucocorticoid resistance in inflammatory diseases. Lancet. 373:1905–1917. 2000.
15	Ito K, Caramori G and Adcock IM: Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther. 321:1–8. 2007.PubMed/NCBI View Article : Google Scholar
16	Ito K, Lim S, Caramori G, Chung KF, Barns PJ and Adcock IM: Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 15:1110–1112. 2001.PubMed/NCBI
17	Barned PJ: Cellular and molecular mechanisms of asthma and COPD. Clin Sci (Lond). 131:1541–1558. 2017.PubMed/NCBI View Article : Google Scholar
18	Kok K, Geering B and Vanhaesebroeck B: Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci. 34:115–127. 2009.PubMed/NCBI View Article : Google Scholar
19	Marwick JA, Caramori G, Casolari P, Mazzoni F, Kirkham PA, Adcock IM, Chung KF and Papi A: A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 125:1146–1153. 2010.PubMed/NCBI View Article : Google Scholar
20	Ichiyama T, Hasegawa S, Matsubara T, Hayashi T and Furukawa S: Theophylline inhibits NF-kappa B activation and I kappa B alpha degradation in human pulmonary epithelial cells. Naunyn Schmiedebergs Arch Pharmacol. 364:558–561. 2001.PubMed/NCBI View Article : Google Scholar
21	Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM and Barns PJ: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 200:689–695. 2004.PubMed/NCBI View Article : Google Scholar
22	Cosio BG, Iglesias A, Rios A, Noguera A, Sala E, Ito K, Barns PJ and Agusti A: Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax. 64:424–429. 2009.PubMed/NCBI View Article : Google Scholar
23	Li M, Zhong X, He Z, Wen M, Li J, Peng X, Liu G, Deng J, Zhang J and Bai J: Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-κB activity in human macrophages in vitro. Int Immunopharmacol. 12:643–650. 2012.PubMed/NCBI View Article : Google Scholar
24	Sun XJ, Li ZH, Zhang Y, Zhou G, Zhang JQ, Deng JM, Bai J, Liu GN, Li MH, MacNee W, et al: Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by cigarette smoke extract through inhibition of PI3K-δ/Akt pathway and increased GR expression. Am J Physiol Lung Cell Mol Physiol. 309:L139–L146. 2015.PubMed/NCBI View Article : Google Scholar
25	Mercado N, To Y, Ito K and Barnes PJ: Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ. J Pharmacol Exp Ther. 337:465–470. 2011.PubMed/NCBI View Article : Google Scholar
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
27	Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE and Barnes PJ: Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 167:24–31. 2003.PubMed/NCBI View Article : Google Scholar
28	Szulakowski P, Crowther AJ, Jimenez LA, Donaldson K, Mayer R, Leonard TB, Macnee W and Drost EM: The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 174:41–50. 2006.PubMed/NCBI View Article : Google Scholar
29	Ngkelo A: The role of GSK3β in regulating corticosteroid function under conditions of oxidative stress in chronic obstructive pulmonary disease. Imperial College 2012.
30	Ortiz JL, Milara J, Lluch J, De Diego A, Sanz C and Cortijo J: Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress. Allergy. 68:64–73. 2013.PubMed/NCBI View Article : Google Scholar
31	Hennessy BT, Smith DL, Ram PT, Lu Y and Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 4:988–1004. 2005.PubMed/NCBI View Article : Google Scholar